Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIFELIKEFALIN vs DIFLUPREDNATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DIFELIKEFALIN vs DIFLUPREDNATE: Safety Overview

Metric DIFELIKEFALIN DIFLUPREDNATE
Total FAERS Reports 363 1,681
Deaths Reported 49 5
Death Rate 13.5% 0.3%
Hospitalizations 110 60
Average Patient Age 71.6 yrs 61.2 yrs
% Female Patients 40.1% 62.8%
FDA Approval Date Aug 23, 2021 Aug 9, 2021
Manufacturer Vifor (International), Inc. Amneal Pharmaceuticals NY LLC
Route INTRAVENOUS OPHTHALMIC
Marketing Status Prescription Prescription